HEPATITIS C RECURRENCE IS A SURROGATE MARKER FOR POOR OUTCOME FOLLOWING LIVER RETRANSPLANTATION

2004 ◽  
Vol 78 ◽  
pp. 395
Author(s):  
J L. Soule ◽  
A J. Olyaei ◽  
J M. Schwartz ◽  
H R. Rosen ◽  
J M. Ham ◽  
...  
2007 ◽  
Vol 46 ◽  
pp. S206
Author(s):  
M.S. Ghabri ◽  
M. Krishna ◽  
V. Machicao ◽  
J. Aranda-Michel ◽  
J. Nguyen ◽  
...  

2016 ◽  
Vol 18 (3) ◽  
pp. 471-479 ◽  
Author(s):  
G. Crespo ◽  
M. Gambato ◽  
O. Millán ◽  
G. Casals ◽  
P. Ruiz ◽  
...  

2009 ◽  
Vol 30 (11) ◽  
pp. 1120-1122 ◽  
Author(s):  
Robert J. Sherertz ◽  
Tobi B. Karchmer

Our report details an implant-associated outbreak of surgical site infections related to the adverse effects of treatment for hepatitis C virus infection administered to surgeon X. During the 12-month period of this outbreak, 14 (9.5%) of 148 of surgeon X's patients developed a surgical site infection, a rate of SSI that was 8-fold higher than the rate during the 14-month baseline period or the 14-month follow-up period (P = .001), and higher than the rate among peer surgeons (P = .02).


2016 ◽  
Vol 100 (3) ◽  
pp. 593-599 ◽  
Author(s):  
Juan Jose Caston ◽  
Luis Castells ◽  
Evaristo Varo ◽  
Miguel Angel Gomez ◽  
Manuel de la Mata ◽  
...  

2010 ◽  
Vol 53 (5) ◽  
pp. 962-970 ◽  
Author(s):  
José A. Carrión ◽  
Miquel Navasa ◽  
Xavier Forns

2007 ◽  
Vol 132 (5) ◽  
pp. 1746-1756 ◽  
Author(s):  
José A. Carrión ◽  
Miquel Navasa ◽  
Montserrat García–Retortillo ◽  
Juan Carlos García–Pagan ◽  
Gonzalo Crespo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document